Palladin Polyclonal Antibody

Rabbit Anti-Palladin Polyclonal Antibody

Product Specifications

Background

PALLD encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The palladin, cytoskeletal associated protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.

CAS Number

9007-83-4

Product Name Alternative

PALLD; KIAA0992; CGI-151; Palladin; SIH002; Sarcoma antigen NY-SAR-77

Gene ID

23022

Accession Number

Q8WX93

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human Palladin at AA rangle: 450-530

Clonality

Polyclonal

Tag

Palladin

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

150kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

Palladin Polyclonal Antibody detects endogenous levels of Palladin protein.

Observed Molecular Weight

150

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:20000; IF 1:50-200